Actuate Therapeutics (ACTU) vs AEON Biopharma (AEON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AEON Biopharma (AEON) has outperformed Actuate Therapeutics (ACTU) over the past year, losing 66.7% versus a loss of 89.7%. Actuate Therapeutics is the larger company by market cap ($16.1 million vs $15.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACTU | AEON |
|---|---|---|
| Share price | $0.6701 | $0.3171 |
| Market cap | $16.09M | $15.82M |
| 1-day change | -7.47% | +1.90% |
| YTD return | -88.17% | -71.70% |
| 1-year return | -89.71% | -66.71% |
| EPS (TTM) | $-0.87 | $-4.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.49 | $1.45 |
| 52-week low | $0.604 | $0.177 |
| Distance from 52-week high | -92.11% | -78.13% |
| Average volume | 391.80K | 8.58M |
| Shares outstanding | 24.01M | 49.88M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AEON has outperformed ACTU by 23.0 percentage points over the past year.
ACTU vs AEON FAQ
Which is bigger, Actuate Therapeutics or AEON Biopharma?
Actuate Therapeutics (ACTU) is larger, with a market capitalization of $16.09M compared with $15.82M for AEON Biopharma (AEON).
Which stock has performed better over the past year, ACTU or AEON?
AEON returned -66.71% over the past 12 months, compared with -89.71% for ACTU (price return, excluding dividends). Past performance does not predict future results.
Are Actuate Therapeutics and AEON Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.